You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mGluR5

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective

Recruiting
  • Major Depressive Disorder
  • Bipolar Disorder
  • Changsha, Hunan, China
    Mental Health Institute & Faculty of Psychiatry of The Second Xi
Apr 23, 2023

Familial Alcoholism Vulnerability Trial in Hartford (Mavoglurant (AFQ056), Placebo)

Completed
  • Familial Alcoholism Vulnerability
  • Mavoglurant (AFQ056)
  • Placebo
  • Hartford, Connecticut
    Hartford Hospital
Jan 7, 2022

Alcohol Use Disorder Trial in Charleston (Placebo, GET73)

Recruiting
  • Alcohol Use Disorder
  • Charleston, South Carolina
    Charleston Alcohol Research Center, Institute of Psychiatry, Med
Jan 5, 2022

Amyotrophic Lateral Sclerosis Trial in St. Gallen ([ 18 F]PSS232)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • [ 18 F]PSS232
  • St. Gallen, Switzerland
    Neuromuscular Center/ALS Clinic, Cantonal Hospital St. Gallen
Apr 19, 2022

Cannabis Use Disorder Trial in New Haven ([18F]FPEB with PET, Cannabis abstinence)

Not yet recruiting
  • Cannabis Use Disorder
  • [18F]FPEB with PET
  • Cannabis abstinence
  • New Haven, Connecticut
    The Anlyan Center
Dec 22, 2022

Alzheimer's Disease Trial in New Haven, West Bend (BMS-984923, Placebo)

Recruiting
  • Alzheimer's Disease
  • New Haven, Connecticut
  • +1 more
Mar 27, 2023

Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)

Suspended
  • Disorder of Consciousness
  • Traumatic Brain Injury
  • Amantadine + L-DOPA
  • NMDA blocker
  • New York, New York
    Weill Cornell Medicine
Sep 27, 2022

Depression; MDD Trial in Stony Brook (Sleep Deprivation)

Recruiting
  • Depression; Major Depressive Disorder
  • Sleep Deprivation
  • Stony Brook, New York
    Stony Brook University Hospital
Jan 30, 2022

Alzheimer Trial in New Haven (BMS-984923)

Completed
  • Alzheimer Disease
  • New Haven, Connecticut
    Yale University
Oct 4, 2022

Trigeminal Neuralgia Trial in Worldwide (Basimglurant, Placebo)

Recruiting
  • Trigeminal Neuralgia
  • La Jolla, California
  • +27 more
Dec 21, 2022

mGluR5 Receptors Trial run by the NIMH (STX107)

Completed
  • mGluR5 Receptors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 26, 2018

Schizophrenia Trial (PET/SPECT Scan, MRI Scan)

Terminated
Has Results
  • Schizophrenia
  • PET/SPECT Scan
  • MRI Scan
  • (no location specified)
May 19, 2020

Healthy, Glutamate Receptor, mGlur5 Protein Trial run by the NIMH ([18F]SP203)

Completed
  • Healthy
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018

Healthy Trial (Ketamine, Ts-134, Placebo)

Recruiting
  • Healthy
  • New York, New York
    NYSPI
Jan 3, 2023

Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

Recruiting
  • Tuberous Sclerosis Complex
  • Basimglurant with crossover to Placebo
  • Placebo with crossover to Basimglurant
  • Phoenix, Arizona
  • +47 more
Jan 3, 2023

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Jun 26, 2023

Brain Glutamate Receptors and Cocaine Dependence

Terminated
  • Drug Abuse
  • Cocaine Dependence
    • Baltimore, Maryland
      National Institute on Drug Abuse, Biomedical Research Center (BR
    Jul 3, 2018

    Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • +2 more
    • New Haven, Connecticut
      Yale University
    Aug 8, 2022

    Sleep Deprivation Trial (Prolonged wakefulness)

    Completed
    • Sleep Deprivation
    • Prolonged wakefulness
    • (no location specified)
    Jan 25, 2021

    Mechanisms of Auto-immune Encephalitis

    Completed
    • Autoimmune Encephalitis
    • Fundamental research
    • Bron, France
      Institut NeuroMyoGène Équipe Synaptopathies et Autoanticorps (Sy
    Jul 28, 2020

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      Attention Deficit Disorder With Hyperactivity Trial in Baltimore (NFC-1, Placebo)

      Completed
      Has Results
      • Attention Deficit Disorder With Hyperactivity
      • Baltimore, Maryland
        The Clinical Trials Center at Kennedy Krieger Institute
      Aug 2, 2021

      ADHD Trial in Wayne (AEVI-001, Placebo)

      Completed
      Has Results
      • Attention Deficit Hyperactivity Disorder
      • Wayne, Pennsylvania
        Aevi Genomic Medicine
      Jul 2, 2021

      Neurofibromatosis 1 Trial in Cincinnati (N-Acetyl cysteine, Placebo)

      Recruiting
      • Neurofibromatosis 1
      • N-Acetyl cysteine
      • Placebo
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Feb 24, 2022

      Autistic Disorder Trial in Nazareth (Erchonia HLS Laser, Placebo Laser)

      Completed
      Has Results
      • Autistic Disorder
      • Erchonia HLS Laser
      • Placebo Laser
      • Nazareth, Israel
        Institute for Brain and Rehabilitation Sciences
      May 26, 2021